Development of cell therapy using hiPS-derived nephron progenitors
| Project/Area Number |
25860674
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | 再生医学 / ネフロン前駆細胞 / 急性腎不全 / iPS細胞 / 腎前駆細胞 / 急性腎障害 / 国際情報交換 アメリカ合衆国 |
|---|
| Outline of Final Research Achievements |
In this study, we generated double reporter hiPSC lines, allowing us to monitor and isolate OSR1+SIX2+ nephron progenitors. We then established a multistep differentiation protocol from hiPSCs into OSR1+SIX2+ nephron progenitors with the induction efficiency nearly 40%. These human nephron progenitors differentiate into multiple renal epithelia including glomerular podocytes and tubular cells, and reconstitute three-dimensional renal structures in vitro and in vivo. Moreover, we found that renal subcapsular transplantation of hiPSC-derived OSR1+SIX2+ nephron progenitors ameliorated acute kidney injury in mice induced by ischemic reperfusion injury. Our results suggest that regenerative medicine strategies for kidney diseases could be developed using the hiPSC-derived renal cells.
|
Report
(3 results)
Research Products
(5 results)
